Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Operating Margin: 2010-2025

Historic Operating Margin for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Sep 2025 value amounting to 17.20%.

  • Arrowhead Pharmaceuticals' Operating Margin fell 109022.00% to 17.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.86%, marking a year-over-year decrease of 255313.00%. This contributed to the annual value of 11.86% for FY2025, which is 1693892.00% up from last year.
  • According to the latest figures from Q3 2025, Arrowhead Pharmaceuticals' Operating Margin is 17.20%, which was up 102.88% from -596.21% recorded in Q2 2025.
  • Arrowhead Pharmaceuticals' Operating Margin's 5-year high stood at 3,457.81% during Q2 2024, with a 5-year trough of -6,456.48% in Q4 2024.
  • For the 3-year period, Arrowhead Pharmaceuticals' Operating Margin averaged around -526.57%, with its median value being 17.20% (2025).
  • In the last 5 years, Arrowhead Pharmaceuticals' Operating Margin soared by 410,681bps in 2024 and then crashed by 405,402bps in 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Operating Margin (Quarterly) stood at -230.77% in 2021, then surged by 16,341bps to -67.36% in 2022, then slumped by 377,789bps to -3,845.25% in 2023, then tumbled by 261,123bps to -6,456.48% in 2024, then slumped by 109,022bps to 17.20% in 2025.
  • Its Operating Margin stands at 17.20% for Q3 2025, versus -596.21% for Q2 2025 and 70.24% for Q1 2025.